Literature DB >> 22311610

A synergy between incretin effect and intestinal gluconeogenesis accounting for the rapid metabolic benefits of gastric bypass surgery.

Gilles Mithieux1.   

Abstract

The early improvement of glucose control taking place shortly after gastric bypass surgery in obese diabetic patients has long been mysterious. A recent study in mice has highlighted some specific mechanisms underlying this phenomenon. The specificity of gastric bypass in obese diabetic mice relates to major changes in the sensations of hunger and to rapid improvement of glucose parameters. The induction of intestinal gluconeogenesis plays a major role in diminishing hunger, and in restoring insulin sensitivity of endogenous glucose production. In parallel, the restoration of the secretion of glucagon-like peptide 1 and insulin plays a key additional role, in this context of recovered insulin sensitivity, to improve postprandial glucose tolerance. Therefore, a synergy between an incretin effect and intestinal gluconeogenesis is a key feature accounting for the rapid improvement of glucose control in obese diabetic patients after bypass surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311610     DOI: 10.1007/s11892-012-0257-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  27 in total

1.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.

Authors:  Stephanie Troy; Maud Soty; Lara Ribeiro; Laure Laval; Stéphanie Migrenne; Xavier Fioramonti; Bruno Pillot; Veronique Fauveau; Roberte Aubert; Benoit Viollet; Marc Foretz; Jocelyne Leclerc; Adeline Duchampt; Carine Zitoun; Bernard Thorens; Christophe Magnan; Gilles Mithieux; Fabrizio Andreelli
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

2.  Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin.

Authors:  Bruno Pillot; Maud Soty; Amandine Gautier-Stein; Carine Zitoun; Gilles Mithieux
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

3.  Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis.

Authors:  Armelle Penhoat; Elodie Mutel; Marta Amigo-Correig; Bruno Pillot; Anne Stefanutti; Fabienne Rajas; Gilles Mithieux
Journal:  Physiol Behav       Date:  2011-03-21

4.  The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats.

Authors:  F Rajas; N Bruni; S Montano; C Zitoun; G Mithieux
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

5.  Liver microsomal glucose-6-phosphatase is competitively inhibited by the lipid products of phosphatidylinositol 3-kinase.

Authors:  G Mithieux; N Daniele; B Payrastre; C Zitoun
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice.

Authors:  R Burcelin; W Dolci; B Thorens
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

7.  Is intestinal gluconeogenesis a key factor in the early changes in glucose homeostasis following gastric bypass?

Authors:  Mark Thomas Hayes; Jonathan Foo; Vinko Besic; Yulia Tychinskaya; Richard Strawson Stubbs
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

8.  Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats.

Authors:  G Mithieux; H Vidal; C Zitoun; N Bruni; N Daniele; C Minassian
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

9.  Rat small intestine is an insulin-sensitive gluconeogenic organ.

Authors:  M Croset; F Rajas; C Zitoun; J M Hurot; S Montano; G Mithieux
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

10.  Differential time course of liver and kidney glucose-6 phosphatase activity during fasting in rats.

Authors:  C Minassian; G Mithieux
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1994-09       Impact factor: 2.231

View more
  5 in total

1.  Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.

Authors:  Dong Sun; Kexin Wang; Zhibo Yan; Guangyong Zhang; Shaozhuang Liu; Fengjun Liu; Chunxiao Hu; Sanyuan Hu
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.

Authors:  H Honka; J Mäkinen; J C Hannukainen; M Tarkia; V Oikonen; M Teräs; V Fagerholm; T Ishizu; A Saraste; C Stark; T Vähäsilta; P Salminen; A Kirjavainen; M Soinio; A Gastaldelli; J Knuuti; P Iozzo; P Nuutila
Journal:  Diabetologia       Date:  2013-01-20       Impact factor: 10.122

3.  Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery.

Authors:  Jaakko Mäkinen; Jarna C Hannukainen; Anna Karmi; Heidi M Immonen; Minna Soinio; Lassi Nelimarkka; Nina Savisto; Mika Helmiö; Jari Ovaska; Paulina Salminen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetologia       Date:  2015-01-29       Impact factor: 10.122

4.  Sodium-glucose co-transporter 1 (SGLT1) differentially regulates gluconeogenesis and GLP-1 receptor (GLP-1R) expression in different diabetic rats: a preliminary validation of the hypothesis of "SGLT1 bridge" as an indication for "surgical diabetes".

Authors:  Hengliang Zhu; Huajie Cai; Xiaokun Wang; Tao Chen; Chaohui Zhen; Zhenzhan Zhang; Xiaojiao Ruan; Guoxin Li
Journal:  Ann Transl Med       Date:  2022-04

5.  β-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies.

Authors:  Ana Carolina Junqueira Vasques; José Carlos Pareja; Maria da Saude de Oliveira; Fernanda Satake Novaes; Marcelo Miranda de Oliveira Lima; Élinton A Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze
Journal:  Diabetes Care       Date:  2013-10-17       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.